Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Takeda claims novel carbapenems

April 26, 1996

VP-63843 effective in phase II

April 19, 1996

DepoAmikacin phase I trial completed

April 19, 1996

Abelcet trial results in children favorable

April 19, 1996

Cefdinir close to filing in U.S.

April 19, 1996

New patent issued to Interferon Sciences

April 12, 1996

Anti-HSV compound karalicin

April 12, 1996

Dutch approval for Amphocil

April 12, 1996

S-28679, a new interferon biosynthesis inducer from 3M

April 12, 1996

AmBisome approved for marketing in Spain

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...